NEW YORK ( TheStreet) -- CHANGE IN RATINGSBrocade ( BRCD) was upgraded at Pacific Crest to Sector Perform. CEO resignation increases the chances of a takeover or company breakup, Pacific Crest said. Cerner ( CERN) was downgraded at Morgan Stanley from Overweight to Equal-Weight. Bookings growth could slow down in the coming quarters, Morgan Stanley said. Cabot Oil & Gas ( COG) was upgraded at JP Morgan from Neutral to Overweight. $54.50 price target. Company can grow faster than its peers over the coming quarters, JP Morgan said. Cymer ( CYMI) was initiated with a Hold rating at Deutsche Bank. Valuation call, based on a $58 price target, Deutsche Bank said. McKesson ( MCK) was downgraded at Morgan Stanley from Overweight to Equal-Weight. Company is seeing fewer new exclusive generics, Morgan Stanley said. Molycorp ( MCP) was downgraded from Buy to Hold at Dahlman Rose. Estimates were also cut, following the recent bond offering, Dahlman Rose said. Walgreen ( WAG) was upgraded at Morgan Stanley from Underweight to Equal-Weight. ESRX overhang has been removed, but European risks remain. Morgan Stanley said. Wellpoint ( WLP) was downgraded at Morgan Stanley from Overweight to Equal-Weight. Company continues to disappoint with execution, Morgan Stanley said.
STOCK COMMENTS / EPS CHANGES
Agilent Technologies ( A) numbers were cut at Citigroup. Shares are now seen reaching $47. Estimates were also lowered as macro issues lead weak results, Citi said. Buy rating. Aeropostale ( ARO) estimates were lowered at UBS through 2014. Expect continued margin pressure and share repos likely minimal NT, UBS said. Neutral rating and $14 price target. Aeropostale estimates, target reduced at Brean Murray. Estimates were cut through 2014. Company lowered its guidance again, Brean Murray said. Buy rating and nwe $18 price target. Brocade numbers were raised at BMO Capital Markets. Shares are now senn reaching $7. Estimates were also increased on modest increase in revenues and operating margins, BMO said. Market Perform rating. FedEx ( FDX) estimates, target cut were at Goldman Sachs. Estimates were reduced through 2015. Company should see slower volume growth, Goldman said. Buy rating and new $101 price target. Gap ( GPS) numbers were raised at UBS. Shares of GPS are now seen reaching $35. Estimates were also increased on improved execution, UBS said. Neutral rating.